DL-AP5
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


DL-AP5
Description:
DL-AP5 (2-APV) is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 shows significantly antinociceptive activity. DL-AP5 specifically blocks on channels in the rabbit retina[1][2][3].Product Name Alternative:
2-APV; DL-2-Amino-5-phosphonovaleric acidUNSPSC:
12352211Hazard Statement:
H315, H319, H335Target:
IGluRType:
Reference compoundRelated Pathways:
Membrane Transporter/Ion Channel; Neuronal SignalingApplications:
COVID-19-immunoregulationField of Research:
Inflammation/Immunology; Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/dl-ap5.htmlPurity:
98.0Solubility:
H2O : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)Smiles:
NC(CCCP(O)(O)=O)C(O)=OMolecular Formula:
C5H12NO5PMolecular Weight:
197.13Precautions:
H315, H319, H335References & Citations:
[1]Murray CW, et al. Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model. Pain. 1991;44 (2) :179-185.|[2]Massey SC, et al. N-methyl-D-aspartate receptors of ganglion cells in rabbit retina. J Neurophysiol. 1990;63 (1) :16-30.|[3]Jafari-Sabet M. NMDA receptor blockers prevents the facilitatory effects of post-training intra-dorsal hippocampal NMDA and physostigmine on memory retention of passive avoidance learning in rats. Behav Brain Res. 2006 Apr 25;169 (1) :120-7.|[4]Taati M, et al. The effects of DL-AP5 and glutamate on ghrelin-induced feeding behavior in 3-h food-deprived broiler cockerels. J Physiol Biochem. 2011 Jun;67 (2) :217-23.|[5]Chen T, et al. Glutamate-induced rapid induction of Arc/Arg3.1 requires NMDA receptor-mediated phosphorylation of ERK and CREB. Neurosci Lett. 2017 Nov 20;661:23-28.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, 3 years (Powder)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
NMDA ReceptorCAS Number:
[76326-31-3]
